NCT01015833 2022-08-04Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver CancerNational Cancer Institute (NCI)Phase 3 Completed356 enrolled 13 charts